pertuzumab

Summary

pertuzumab is a type of chemical entity^[1]. pertuzumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (274 views/month).^[2]

Key Facts

• pertuzumab's instance of is recorded as type of chemical entity^[3].
• pertuzumab's physically interacts with is recorded as Erb-b2 receptor tyrosine kinase 2^[4].
• pertuzumab is a type of protein^[5].
• pertuzumab is used for medication^[6].
• pertuzumab's Commons category is recorded as Pertuzumab^[7].
• pertuzumab's facet of is recorded as breast cancer^[8].
• pertuzumab's has characteristic is recorded as biopharmaceutical^[9].
• pertuzumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'pertuzumab'}^[10].
• pertuzumab's subject has role is recorded as antineoplastic^[11].
• pertuzumab's subject has role is recorded as immunological antineoplastic agent^[12].
• pertuzumab's subject has role is recorded as monoclonal antibody^[13].
• pertuzumab's subject has role is recorded as developmental toxicant^[14].
• pertuzumab's pregnancy category is recorded as US pregnancy category D^[15].
• pertuzumab's legal status is recorded as boxed warning^[16].
• pertuzumab's active ingredient in is recorded as Perjeta^[17].
• pertuzumab's has active ingredient is recorded as Pertuzumab^[18].

Why It Matters

pertuzumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (274 views/month).^[2] pertuzumab has Wikipedia articles in 13 language editions, a strong signal of global cultural recognition.^[19] pertuzumab is known by 7 alternative names across languages and contexts.^[20]